Key Summary European consortium validated a new pharmaceutical manufacturing model. The PIPAC consortium comprises De Dietrich, Alysophil, Bruker, and Novalix. The technology offers a faster, more flexible pathway from drug development to commercial supply. A European consortium has successfully validated a new pharmaceutical manufacturing model. It is designed to modernise traditional supply chains, reduce dependence on centralised production, and accelerate the industrialisation of critical me